Edwards Lifesciences stock surged Wednesday — and retook both its key moving averages — after beating fourth-quarter forecasts for its heart-valve replacements. Please watch the video at ...

Edwards Lifesciences Corp ... Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio ...

So much in life is determined by being in the right place at the right time, and by being prepared and bold enough to seize opportunities as they present themselves. I was prepared in large part ...

Zacks Research boosted their Q1 2025 earnings estimates for shares of Edwards Lifesciences in a research report issued to ...

Zovighian said the transition to CEO has been relatively smooth since he joined Edwards in 2015 and spent eight years in ...

Over the last two decades, Edwards Lifesciences has demonstrated that it knows how to maintain leadership through innovation of tissue heart valves. Edwards remains the dominant force in surgical ...

Richard Mullins. “The two had a conversation.” Starr convinced Edwards they needed a successful artificial heart valve first and they agreed to embark on an ambitious project, each offering ...

4, 2025. EW stock is on investors' radars due to the promising structural heart opportunities following the divestment of the Critical Care arm. Edwards Lifesciences stock popped Wednesday on ...

Sigma Planning Corp reduced its stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange ...